NEW YORK, Nov. 12 (GenomeWeb News) - Genaissance Pharmaceuticals of New Haven, Conn., today reported revenues of $2.6 million for the third quarter ending Sept. 30, an increase of 47 percent over revenues of $1.8 million for the year-ago quarter.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.